Xiao Le appointed as Chief Investment Officer of Gland Pharma International Pte. Ltd. effective November 9, 2026. Role focuses on enhancing M&A capabilities in the US, China, Singapore, and other ...

UK operations expected to nearly break even in Q4FY27 if imports are cleared. UK Q3FY27 revenue forecasted GBP28-GBP30 per ton higher than Q2FY27. India operations anticipate stronger H2FY27 due to ...

GPCB revoked the direction against Neogen Chemicals' Dahej plant on November 7, 2026. Provisional consent granted for MPP-5 ...

Jubilant Advanced Electronics Limited (JAEL) signed an agreement to acquire 40% stake in Zettaone Technologies. Option exists ...

Alkem Laboratories incorporated 'Alkem Pharma Company' in Saudi Arabia on November 8, 2026. Subsidiary holds 51% stake with a ...

PAT rose 23% YoY to ₹133 million in H1FY27. Revenue from operations grew 16% YoY to ₹1,194 million. Order book reached a ...

Saurashtra Cement received a show cause notice for ₹1.91 crore from GST authorities. Demand relates to non-payment of GST on ...

Manish Rastogi ceased as Zee Learn CEO and Whole-time Director on November 8, 2026. Exit triggered by attaining age of ...

Completed hot trial of Pickling Line and cold trial of GP Line at Mangaon facility. Reported 20.2% year-on-year sales volume ...

Consolidated net loss widened 43.9% YoY to ₹477.19 lakh in Q2FY27. Revenue from operations declined marginally by 1.4% to ...

Growth was driven by buyer transactions, not price increases. Average realisations remained flat compared to the same period last year. Festive season demand and entry-level product momentum boosted ...

Trump described a US return to war with Iran as 'highly improbable' if negotiations proceed. The statement was reported by CNN. The remarks link the probability of military conflict to the ...